Nav: Home

Texting to improve health outcomes for people with schizophrenia

April 23, 2019

Texting patients with schizophrenia and their lay health supporters in a resource-poor community setting is more effective than a free-medicine program alone in improving medication adherence and reducing relapses and re-hospitalizations, according to a study published April 23 in the open-access journal PLOS Medicine by Wenjie Gong of Central South University in Hunan, China, Dong (Roman) Xu of Sun Yat-sen University Global Health Institute, Guangdong, China and colleagues.

Schizophrenia is a leading cause of disability and, in low- and-middle-income countries, the treatment gap remains high; even when treatment is available, adherence to antipsychotics is low. Mobile phone text messaging has been shown to be useful to strengthen community- and family-based care in resource-poor settings due to its availability, reliability, and ease of use. But there has been no clear evidence that texting improves treatment adherence, symptoms or functioning in people with schizophrenia. Gong and colleagues hypothesized that mobile phone texting could improve schizophrenia care in resource-poor community settings compared with a free-medicine, community-based program alone. To test this idea, the researchers developed an intervention called LEAN (Lay health supporters, Electronic platform with mobile texting for medication reminders, health education and monitoring, Award of token gifts for positive behavioral improvement, and iNtegration into health systems).

In this randomized controlled trial, 278 community-dwelling villagers with schizophrenia in Hunan, China were randomized into two groups. Both groups received a nationwide community-based mental health program that provided free antipsychotic medications, and participants in the intervention group also received LEAN, which featured a lay health supporter and text messages for medication reminders, health education, monitoring of early signs of relapses, and facilitated linkage to primary health care. The results showed significant improvement in medication adherence with a mean of 0.48 in the control group, where 1 represents complete adherence in the past month, as compared with 0.61 in the intervention group at 6 months (adjusted mean difference 0.12 [95% CI 0.03-0.22, p=0.013]). This 27% relative improvement is larger than the 15-18% range reported for other text-message interventions. Moreover, there was an apparent reduction in the risk of relapse in 34.2% (40 of 117) control participants as compared with 21.7% (26 of 120) interventional participants, and a decrease in re-hospitalizations in 20.5% (25 of 122) controls as compared with 7.3% (9 of 123) interventional participants. According to the authors, texting was able to effectively address low medication adherence at marginal cost in rural China, and further research could investigate the LEAN program for potential benefits in people with schizophrenia in other low- and-middle-income countries with resource constraints.
-end-
Research Article

Funding:

The project received grant support from the China Medical Board (https://chinamedicalboard.org/; grant number 12-114, WG, PI) and NIH (https://fogartycenter.org; research training grant #R25 TW009345, DX, Fogarty fellowship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing Interests:

The authors have declared that no competing interests exist.

Citation:

Xu D, Xiao S, He H, Caine ED, Gloyd S, Simoni J, et al. (2019) Lay health supporters aided by mobile text messaging to improve adherence, symptoms, and functioning among people with schizophrenia in a resource-poor community in rural China (LEAN): A randomized controlled trial. PLoS Med 16(4): e1002785. https://doi.org/10.1371/journal.pmed.1002785

Author Affiliations:

Sun Yat-sen Global Health Institute, School of Public Health and Institute of National Governance, Sun Yat-sen University, Guangzhou, Guangdong, China

Xiangya School of Public Health, Central South University, Changsha, Hunan, China

Department of Epidemiology, School of Public Health and Tropical Medicine, Tulane University, New Orleans, Louisiana, United States of America

Department of Psychiatry, University of Rochester Medical Center, Rochester, New York, United States of America

Department of Global Health, University of Washington, Seattle, Washington, United States of America

Department of Psychology, University of Washington, Seattle, Washington, United States of America

Department of Biostatistics, University of Washington, Seattle, Washington, United States of America

Silver School of Social Work, New York University, New York, New York, United States of America

In your coverage please use this URL to provide access to the freely available paper: http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002785

PLOS

Related Schizophrenia Articles:

First physiological test for schizophrenia and depression
Researchers have found a new way of using proteins in nerve cells to identify people with depression and schizophrenia.
The emergence of a new dopamine hypothesis of schizophrenia
Biological Psychiatry presents a special issue, 'The Dopamine Hypothesis of Schizophrenia,' dedicated to recent advances in understanding the role of dopamine signaling in schizophrenia.
Progress in refining the genetic causes of schizophrenia
An international study led by the University of Exeter Medical School has made advances in understanding the ways in which genetic risk factors alter gene function in schizophrenia.
Exercise can tackle symptoms of schizophrenia
Aerobic exercise can significantly help people coping with the long-term mental health condition schizophrenia, according to a new study from University of Manchester researchers.
In search of neurobiological factors for schizophrenia
It is impossible to predict the onset of schizophrenic psychosis.
A comparison between quetiapine and aripiprazole for treatment of schizophrenia
Schizophrenia is a common cause of incapacity and is ranked as the third most disabling illness subsequent to dementia and quadriplegia.
Four new genetic diseases defined within schizophrenia
Changes in key genes define four previously unknown conditions within schizophrenia, according to a study led by researchers from NYU Langone Medical Center published online April 28 in EBioMedicine, a Lancet journal.
Decrypting a collagen's role in schizophrenia
A small peptide generated from a collagen protein may protect the brain from schizophrenia by promoting the formation of neuronal synapses, according to a paper published in The Journal of Cell Biology.
Two in 5 individuals with schizophrenia have attempted suicide
A new study by the University of Toronto (U of T), released today, found that those with schizophrenia who'd been physically abused during childhood were five times more likely to have attempted suicide.
'Schizophrenia' does not exist, argues expert
The term 'schizophrenia,' with its connotation of hopeless chronic brain disease, should be dropped and replaced with something like 'psychosis spectrum syndrome,' argues a professor of psychiatry in The BMJ today.

Related Schizophrenia Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Anthropomorphic
Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#SB2 2019 Science Birthday Minisode: Mary Golda Ross
Our second annual Science Birthday is here, and this year we celebrate the wonderful Mary Golda Ross, born 9 August 1908. She died in 2008 at age 99, but left a lasting mark on the science of rocketry and space exploration as an early woman in engineering, and one of the first Native Americans in engineering. Join Rachelle and Bethany for this very special birthday minisode celebrating Mary and her achievements. Thanks to our Patreons who make this show possible! Read more about Mary G. Ross: Interview with Mary Ross on Lash Publications International, by Laurel Sheppard Meet Mary Golda...